CTSO · Cytosorbents Corp
Market Cap
$21.61M
Shares
62.84M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, PhD Chief Executive Officer | $808,431 |
| Vincent Capponi | MS President and Chief Operating Officer | $714,372 |
| Efthymios Deliargyris | Chief Medical Officer | $663,455 |
| Peter Mariani | CFO | $659,872 |
| Peter J. Mariani | Chief Financial Officer | $659,872 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, Chief Executive Officer Peter J. Mariani | $899,695 |
| Vincent Capponi | MS President and Chief Operating Officer | $852,037 |
| Efthymios Deliargyris | Chief Medical Officer | $813,442 |
| Peter Mariani | CFO | $584,765 |
| Peter J. Mariani | Chief Financial Officer | $584,765 |
| Kathleen P. Bloch | Former Chief Financial Officer | $436,423 |
| Kathleen Bloch | CFO | $436,423 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, Chief Executive Officer Peter J. Mariani | $1,333,402 |
| Vincent Capponi | MS President and Chief Operating Officer | $1,112,255 |
| Efthymios Deliargyris | Chief Medical Officer | $1,055,732 |
| Kathleen P. Bloch | Former Chief Financial Officer | $816,084 |
| Kathleen Bloch | CFO | $816,084 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, PhD Chief Executive Officer | $1,790,596 |
| Vincent Capponi | MS President and Chief Operating Officer | $1,486,221 |
| Kathleen Bloch | CFO | $1,248,680 |
| Kathleen P. Bloch | MBA, CPA Chief Financial Officer | $1,248,680 |
| Efthymios Deliargyris | Chief Medical Officer | $1,194,718 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, PhD Chief Executive Officer | $1,388,190 |
| Vincent Capponi | MS President and Chief Operating Officer | $1,178,697 |
| Kathleen Bloch | CFO | $970,871 |
| Kathleen P. Bloch | MBA, CPA Chief Financial Officer | $970,871 |
| Efthymios Deliargyris | Chief Medical Officer | $827,218 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, PhD Chief Executive Officer | $1,404,376 |
| Vincent Capponi | MS President and Chief Operating Officer | $1,169,600 |
| Kathleen Bloch | CFO | $999,847 |
| Kathleen P. Bloch | MBA, CPA Chief Financial Officer | $999,847 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, PhD Chief Executive Officer | $1,247,295 |
| Vincent Capponi | MS President and Chief Operating Officer | $1,079,620 |
| Kathleen Bloch | CFO | $953,583 |
| Kathleen P. Bloch | MBA, CPA Chief Financial Officer | $953,583 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Phillip Chan | MD, PhD President and Chief Executive Officer | $827,597 |
| Vincent Capponi | MS Chief Operating Officer | $713,438 |
| Kathleen Bloch | CFO | $626,614 |
| Kathleen P. Bloch | MBA, CPA Chief Financial Officer | $626,614 |
Key facts
CIK
1175151
CUSIP
23283X206
13F (30d)
43 filings
43 filers
Visit website
Investor relations